How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/topical-lyophilized-exosomes-application.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-09 · How we verify

Topical lyophilized exosomes application — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Topical lyophilized exosomes application (Topical lyophilized exosomes application) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Exosome therapy. Area: Ophthalmology.

marketed Exosome therapy Ophthalmology Biologic Live · refreshed every 30 min

Target snapshot

Topical lyophilized exosomes application (Topical lyophilized exosomes application) — Instituto de Oftalmología Fundación Conde de Valenciana. Lyophilized exosomes delivered topically to the eye promote tissue repair and regeneration through delivery of bioactive molecules and stimulation of endogenous healing pathways.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Topical lyophilized exosomes application TARGET	Topical lyophilized exosomes application	Instituto de Oftalmología Fundación Conde de Valenciana	marketed	Exosome therapy
ExoFlo	ExoFlo	Direct Biologics, LLC	phase 3	Exosome therapy
CardiolRx	CardiolRx	Cardiol Therapeutics Inc.	phase 3	Exosome therapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Exosome therapy class)

Cardiol Therapeutics Inc. · 1 drug in this class
Direct Biologics, LLC · 1 drug in this class
Instituto de Oftalmología Fundación Conde de Valenciana · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Topical lyophilized exosomes application — Competitive Intelligence Brief. https://druglandscape.com/ci/topical-lyophilized-exosomes-application. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing